Two adults with weakened immune systems who received investigational fecal microbiota transplantations developed invasive infections caused by extended-spectrum beta-lactamase -producing Escherichia coli, according to an FDA press release.
One of those individuals subsequently died.
As a result, the FDA issued a safety alert on Thursday to inform health care providers and patients of the possible risks for contracting serious infections when using FMT.
The FMT conducted in the two patients was prepared from stool obtained from the same donor, according to the release. However, according to the

Source link